May 1st, 2024
Contrave Gaining Weight Loss Market Share
Currax Chief Executive Officer George Hampton discusses the success of its Contrave weight loss drug and how it differs from GLP-1s. He speaks with Bloomberg's Katie Greifeld on "Bloomberg Markets."











